JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 4 660-666
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dresel, S. H.J.
Right arrow Articles by Kung, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dresel, S. H.J.
Right arrow Articles by Kung, H. F.

Simultaneous SPECT Studies of Pre- and Postsynaptic Dopamine Binding Sites in Baboons

Stefan H.J. Dresel, Mei-Ping Kung, Xiao-Feng Huang, Karl Plössl, Catherine Hou, Sanath K. Meegalla, Gregory Patselas, Mu Mu, Janet R. Saffer and Hank F. Kung

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: Stefan H.J. Dresel, MD, Department of Radiology, University of Pennsylvania, 3700 Market St., Room 305, Philadelphia, PA 19104.

ABSTRACT

The central nervous system dopamine transporters (DAT5) and dopamine D2/D3 receptors are implicated in a variety of neurological disorders. Both sites are also targets for drug treatment. With the successful development of [99mTc]TRODAT-1, single isotope imaging studies using this ligand for DAT imaging can be complemented by additional use of 123I-labeled D2/D3 receptor ligand co-injected to assess both pre- and postsynaptic sites of the dopaminergic system simultaneously. Methods: Twelve SPECT scans of the brain were obtained in two baboons after intravenous administration of 740 MBq (20 mCi) [99mTc]-TRODAT-1 (technetium, [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl) amino]ethyl]-amino]ethanethiolato (3-)]- oxo-[1R-(exo-exo)]) and 185 MBq (5 mCi) [123l]iodobenzamide or [123l]iodobenzofuran. SPECT data were acquired by a triple-head gamma camera equipped with ultra-high-resolution fanbeam collimators (scan duration = 210 min). Two sets of SPECT data were obtained using energy windows of 15% centered on 140 keV for 99mTc and 10% asymmetric with a lower bound at 159 keV for 123l. After coregistration with MRI, region-of-interest analysis was performed using predefined templates from coregistered MRI. In blocking studies, baboons were pretreated with N-methyl-2ß-carbomethoxy-3ß-(4-fluorophenyl)tropane (CFT, 14 mg) or raclopride (14 mg) to block DAT or D2/D3 binding site, respectively. Results: Image quality of dual-isotope studies was similar to that obtained from single-isotope studies. When one site was blocked with CFT or raclopride, the binding of the respective ligand to the other site was not affected. Conclusion: This is the first example that clearly demonstrates the feasibility of simultaneous imaging of both pre-and postsynaptic sites of the dopaminergic system in baboons with dual-isotope SPECT studies. With or without corrections for cross-contamination of 123l into the 99mTc window, striatum-to-cerebellum ratios (target-to-nontarget) of dual-isotope experiments did not differ significantly from single-isotope experiments. This method may be a valuable and cost-effective tool for gaining comprehensive information about the dopaminergic system in one SPECT imaging session.

Key Words: dopamine transporters • dopamine D2/D3 receptors • SPECT imaging • dual-isotope studies




This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
M. D. Ohlmeier, K. Peters, B. T. T. Wildt, M. Zedler, M. Ziegenbein, B. Wiese, H. M. Emrich, and U. Schneider
Comorbidity of Alcohol and Substance Dependence with Attention-Deficit/Hyperactivity Disorder (ADHD)
Alcohol Alcohol., March 7, 2008; (2008) agn014v1.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G. J. E Schmitt, E. M. Meisenzahl, T. Frodl, C. La Fougere, K. Hahn, H- J. Moller, and S. Dresel
The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1
J Psychopharmacol, September 1, 2005; 19(5): 488 - 493.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
Y. K. Yang, L. Yu, T. L. Yeh, N. T. Chiu, P. S. Chen, and I H. Lee
Associated Alterations of Striatal Dopamine D2/D3 Receptor and Transporter Binding in Drug-Naive Patients With Schizophrenia: A Dual-Isotope SPECT Study
Am J Psychiatry, August 1, 2004; 161(8): 1496 - 1498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.